Short Term Effectiveness Study of Juxta-Fit Versus Trico Bandages in the Treatment of Leg Lymphedema
Primary Purpose
Lymphedema
Status
Completed
Phase
Phase 4
Locations
Netherlands
Study Type
Interventional
Intervention
bandaging with trico as active controller
Sponsored by

About this trial
This is an interventional treatment trial for Lymphedema focused on measuring lymphedema, conservative treatment, compression therapy, interface pressure
Eligibility Criteria
Inclusion criteria:
- Gender: male or female
- More than 18 years of age
- Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging of the leg stage 2/3 (pitting component)
- The patient is able to understand the study and is willing to give written informed consent to the study.
Exclusion criteria:
- Allergy to one of the used materials
- Proximal lymphedema (involvement of thigh, genitalia)
- Severe systemic diseases causing peripheral edema
- Acute superficial or deep vein thrombosis
- Arterial occlusive disease (stadium II, III or IV) Ankle Brachial Pulse Index (ABPI) <0,8
- Local infection in the therapy area
- Auto-immunological disorders or vasculitis
- Use of systemic corticosteroids
- Inability to don, doff, and adjust the Juxta-Fit
- If the ankle circumference around the malleoli is greater than 38cm or if the difference between the arch circumference and the circumference around the base of the toes is greater than 7cm.
Sites / Locations
- Nij Smellinghe hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
trico bandage
juxta fit compression device
Arm Description
Leg lymphedema stage 2-3
leg lymphedema stage 2/3
Outcomes
Primary Outcome Measures
Efficacy of a device initial made for the maintenance treatment phase, which is now used in the initial treatment phase during 24 hour
Secondary Outcome Measures
Quality of life (Visual Analog Scale) and number of self-management interventions by the patient in the study group
Full Information
NCT ID
NCT01068431
First Posted
February 3, 2010
Last Updated
December 4, 2012
Sponsor
Nij Smellinghe Hosptial
1. Study Identification
Unique Protocol Identification Number
NCT01068431
Brief Title
Short Term Effectiveness Study of Juxta-Fit Versus Trico Bandages in the Treatment of Leg Lymphedema
Official Title
Prospective, Randomized Controlled Trial Comparing the Effect of CircAid(R) Juxta-Fit(tm) Versus Trico Bandages in the Treatment of Leg Lymphedema
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
February 2010 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
August 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nij Smellinghe Hosptial
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Juxta-Fit is used for compression treatment. Juxta-Fit is an inelastic compression device which can be easily adjusted to the circumference of the limb and is usually used during the maintenance phase of lymphedema treatment. The aim of the study is to assess the effectiveness of Juxta-Fit in the initial treatment phase of leg lymphedema compared to the traditional treatment with Trico bandages in relation to interface pressure and to explore if self-management by Juxta fit is efficient after a short demonstration. Data are collected at 0-2-24 hours
Detailed Description
Application of marketed compression systems (Juxta-Fit or Trico bandages) used for treatment by trained specialists with assessment of the interface pressure and volume reduction. For the first two hours, bandages and Juxta fit will be applied by experienced medical staff and the use of the juxta-fit device will be explained to the patient. Thereafter the devices will be removed and patients in the Juxta fit group will apply the device themselves in the treatment. In this second phase after 2 hours, patients may adjust the Juxta-Fit according to their needs and comfort when they feel the device is getting too loose as activity of self-management during 24 hours. The patient will document this in a diary.
Detailed measuring data:
Volumetry:
Measurements after 0h, 2h and 24 h by using classic water displacement apparatus.
Pressure:
Measurements after 0h, 2h (pre and post system change) and 24 h at the B1 region:
Supine and standing to calculate the Static Stiffness Index (SSI);
Supine with and without dorsal flexion to calculate the Dynamic Stiffness index (DSI).
Circumference measurement as safety parameter At 5 cm above the upper part of the patella the circumference is measured at 0-2-24 hours to monitor eventual fluids shift.
Questionnaire
- The Visual Analog Scale (VAS) is used at 0 (pre-treatment), 2 and 24 hours to register the comfort of the materials used.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lymphedema
Keywords
lymphedema, conservative treatment, compression therapy, interface pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
trico bandage
Arm Type
Active Comparator
Arm Description
Leg lymphedema stage 2-3
Arm Title
juxta fit compression device
Arm Type
Experimental
Arm Description
leg lymphedema stage 2/3
Intervention Type
Other
Intervention Name(s)
bandaging with trico as active controller
Other Intervention Name(s)
Trico bandages (BSNmedical)
Intervention Description
In general non-elastic bandaging is the compression treatment in lymphedema
Primary Outcome Measure Information:
Title
Efficacy of a device initial made for the maintenance treatment phase, which is now used in the initial treatment phase during 24 hour
Time Frame
short term study during 26 hours
Secondary Outcome Measure Information:
Title
Quality of life (Visual Analog Scale) and number of self-management interventions by the patient in the study group
Time Frame
short term study during 26 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Gender: male or female
More than 18 years of age
Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging of the leg stage 2/3 (pitting component)
The patient is able to understand the study and is willing to give written informed consent to the study.
Exclusion criteria:
Allergy to one of the used materials
Proximal lymphedema (involvement of thigh, genitalia)
Severe systemic diseases causing peripheral edema
Acute superficial or deep vein thrombosis
Arterial occlusive disease (stadium II, III or IV) Ankle Brachial Pulse Index (ABPI) <0,8
Local infection in the therapy area
Auto-immunological disorders or vasculitis
Use of systemic corticosteroids
Inability to don, doff, and adjust the Juxta-Fit
If the ankle circumference around the malleoli is greater than 38cm or if the difference between the arch circumference and the circumference around the base of the toes is greater than 7cm.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
RJ Damstra, MD PhD
Organizational Affiliation
Nij Smellinghe Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nij Smellinghe hospital
City
Drachten
State/Province
Friesland
ZIP/Postal Code
9200 DA
Country
Netherlands
12. IPD Sharing Statement
Learn more about this trial
Short Term Effectiveness Study of Juxta-Fit Versus Trico Bandages in the Treatment of Leg Lymphedema
We'll reach out to this number within 24 hrs